Mode
Text Size
Log in / Sign up

Cancer

598 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Cancer

How does receptor discordance in metastatic breast cancer impact overall survival rates?

Receptor discordance in metastatic breast cancer is linked to worse overall survival, especially when hormone receptors are lost.

Full answer →
What does a pilot study say about deep longitudinal profiling for metastatic cancer patients?

The provided sources do not contain any pilot study on deep longitudinal profiling for metastatic cancer patients.

Full answer →
Does having different receptors in metastatic breast cancer lesions affect how long I live?

Yes, different receptor types in metastatic breast cancer lesions are linked to different survival times, with hormone receptor-positive subtypes generally having longer survival than HER2-positive or triple-negative subtypes.

Full answer →
What immune checkpoint inhibitor is best for survival in metastatic cervical cancer?

Pembrolizumab plus chemotherapy is the best-supported immune checkpoint inhibitor for improving overall survival in metastatic cervical cancer, especially in PD-L1 positive patients.

Full answer →
Does the neutrophil-to-lymphocyte ratio predict progression-free survival in metastatic cervical cancer patients?

A high neutrophil-to-lymphocyte ratio (NLR) before treatment predicts shorter progression-free survival in metastatic cervical cancer patients receiving immunotherapy, while a low ratio suggests better outcomes.

Full answer →
How does the neutrophil-to-lymphocyte ratio predict survival in metastatic cervical cancer treated with immune therapy?

A lower neutrophil-to-lymphocyte ratio (NLR) before starting immune therapy predicts longer survival and better response rates in metastatic cervical cancer, while a higher ratio signals a worse outlook.

Full answer →
What evidence exists for liver cancer alongside lung, breast, and kidney cancer?

Research shows liver cancer detection using liquid biopsies has high accuracy similar to lung, breast, and kidney cancers, while survival rates for liver cancer have improved significantly in recent years.

Full answer →
Can machine learning with cfDNA help detect liver cancer at different stages?

Yes, machine learning with cfDNA can detect liver cancer at various stages, with sensitivities ranging from 44% for stage I to 99% for stage III and high specificity.

Full answer →
See all 61 questions about Cancer →

All Cancer Articles